Sort   by:  
 Page size 
UnknownA 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol.
Not available
S-EPMC7150643 | biostudies-literature
UnknownPeanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.
Not available
S-EPMC3529994 | biostudies-literature
UnknownSublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.
Not available
S-EPMC4527157 | biostudies-literature
UnknownAllergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
Not available
S-EPMC8995337 | biostudies-literature
UnknownClinical efficacy and immune regulation with peanut oral immunotherapy.
Not available
S-EPMC2725434 | biostudies-literature
UnknownEffects of allergen sensitization on response to therapy in children with eosinophilic esophagitis.
Not available
S-EPMC6166246 | biostudies-literature
UnknownSustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Not available
S-EPMC3960331 | biostudies-literature
UnknownOral immunotherapy for treatment of egg allergy in children.
Not available
S-EPMC3424505 | biostudies-literature
UnknownEpicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
Not available
S-EPMC8612061 | biostudies-literature
UnknownEfficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Not available
S-EPMC9119642 | biostudies-literature
Sort   by:  
 Page size